David Bredt

Companies

• Rapport Therapeutics, Inc.Chief Scientific Officer Jun 6, 2024 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• RTRapport Therapeutics, Inc. RAPP393,075 shares²$11.6M at $29.57Feb 19, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Feb 19, 2026Exercised options 6,000 shares at $1.80 of Rapport Therapeutics, Inc.²
• Feb 17, 2026Sold 2,200 shares at $29.59 of Rapport Therapeutics, Inc.²
• Feb 17, 2026Sold 5,400 shares at $28.95 of Rapport Therapeutics, Inc.²
• Feb 17, 2026Sold 900 shares at $28.02 of Rapport Therapeutics, Inc.²
• Jan 15, 2026Sold 200 shares at $27.40 of Rapport Therapeutics, Inc.³
• Jan 15, 2026Sold 8,300 shares at $26.83 of Rapport Therapeutics, Inc.³
• Dec 31, 2025Sold 6,567 shares at $30.05 of Rapport Therapeutics, Inc.⁴
• Dec 31, 2025Granted 18,000 shares of Rapport Therapeutics, Inc.⁴
• Dec 15, 2025Sold 796 shares at $30.68 of Rapport Therapeutics, Inc.⁵
• Dec 15, 2025Sold 7,704 shares at $29.95 of Rapport Therapeutics, Inc.⁵
• Nov 17, 2025Sold 5,344 shares at $25.39 of Rapport Therapeutics, Inc.⁶
• Nov 17, 2025Sold 3,156 shares at $24.84 of Rapport Therapeutics, Inc.⁶
• Oct 15, 2025Sold 1,082 shares at $26.16 of Rapport Therapeutics, Inc.⁷
• Oct 15, 2025Sold 7,418 shares at $25.73 of Rapport Therapeutics, Inc.⁷
• Sep 15, 2025Sold 3,402 shares at $24.66 of Rapport Therapeutics, Inc.⁸
• Sep 15, 2025Sold 5,098 shares at $23.88 of Rapport Therapeutics, Inc.⁸
• Aug 15, 2025Sold 200 shares at $15.79 of Rapport Therapeutics, Inc.⁹
• Aug 15, 2025Sold 8,300 shares at $14.98 of Rapport Therapeutics, Inc.⁹
• Jul 15, 2025Sold 8,500 shares at $14.00 of Rapport Therapeutics, Inc.¹⁰
• Jun 16, 2025Sold 8,500 shares at $11.00 of Rapport Therapeutics, Inc.¹¹
• May 15, 2025Sold 8,500 shares at $9.56 of Rapport Therapeutics, Inc.¹²
• Apr 15, 2025Sold 8,500 shares at $9.57 of Rapport Therapeutics, Inc.¹³
• Mar 14, 2025Sold 8,500 shares at $10.85 of Rapport Therapeutics, Inc.¹⁴